AN ACQUIRED INHIBITOR TO FACTOR VIIIC IN A NON-HEMOPHILIAC - 20 YEARS OF OBSERVATION AND CHARACTERIZATION

被引：11
|
作者：
COOTS, MC
GLUECK, HI
机构：
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 1987年 / 24卷 / 04期
关键词：
D O I：
10.1002/ajh.2830240411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：415 / 424
页数：10
相关论文
共 50 条
  • [41] ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR
    MOHRI, H
    TANABE, J
    OHTSUKA, M
    YOSHIDA, M
    MOTOMURA, S
    NISHIDA, S
    FUJIMURA, Y
    OKUBO, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 561 - 566
  • [42] ACQUIRED FACTOR-VIII INHIBITOR IN A NON-HEMOPHILIC PATIENT - SUCCESSFUL TREATMENT WITH PLASMA-EXCHANGE ASSOCIATED WITH FACTOR-VIII CONCENTRATE AND IMMUNOSUPPRESSORS
    PARACCHINI, ML
    ROCCHINI, GM
    RENOLDI, P
    FIORINI, GF
    GOSSO, P
    ONIDA, L
    GENIRAM, A
    MARINI, U
    GIBELLI, A
    HAEMOSTASIS, 1984, 14 (03) : 249 - 252
  • [43] 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN THE TREATMENT OF NON-HEMOPHILIC PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITOR
    MUHM, M
    GROIS, N
    KIER, P
    STUMPFLEN, A
    KYRLE, P
    PABINGER, I
    BETTELHEIM, P
    HINTERBERGER, W
    LECHNER, K
    HAEMOSTASIS, 1990, 20 (01) : 15 - 20
  • [44] Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non-Small-Cell Lung Cancer
    Rudin, Charles M.
    Hong, Kelvin
    Streit, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : E41 - E42
  • [45] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    CANCER, 2013, 119 (24) : 4325 - 4332
  • [46] β1 INTEGRIN MEDIATED ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN NON-SMALL LUNG CANCER CELLS
    Deng, Q-F
    Xu, J-F
    Zhou, C-C
    Su, B.
    Zhao, Y-M
    RESPIROLOGY, 2011, 16 : 185 - 185
  • [47] Clinical strategies for acquired epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small-cell lung cancer patients
    Dong, Lijun
    Lei, Dan
    Zhang, Haijun
    ONCOTARGET, 2017, 8 (38) : 64600 - 64606
  • [48] β1 integrin mediated acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor in non-small lung cancer cells
    Deng, Q.
    Zhou, S.
    Su, B.
    Zhao, Y.
    Zhou, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer
    Meng Wang
    Jing Zhao
    Lian-Min Zhang
    Hui Li
    Jin-Pu Yu
    Xiu-Bao Ren
    Chang-Li Wang
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 2069 - 2077
  • [50] Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance
    Tartarone, Alfredo
    Lerose, Rosa
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (05) : 242 - 250
12345